| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/BJC.2011.543 |
| P953 | full work available at URL | http://www.nature.com/articles/bjc2011543 |
| http://www.nature.com/articles/bjc2011543.pdf | ||
| https://europepmc.org/articles/PMC3262130 | ||
| https://europepmc.org/articles/PMC3262130?pdf=render | ||
| https://www.nature.com/articles/bjc2011543.pdf | ||
| P932 | PMC publication ID | 3262130 |
| P698 | PubMed publication ID | 22166799 |
| P5875 | ResearchGate publication ID | 51875962 |
| P2093 | author name string | G. Roti | |
| K. Stegmaier | |||
| P2860 | cites work | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
| Identification of AML1-ETO modulators by chemical genomics | Q24643359 | ||
| A small molecule that binds Hedgehog and blocks its signaling in human cells | Q24646445 | ||
| Functional discovery via a compendium of expression profiles | Q27938962 | ||
| Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics | Q28131742 | ||
| Quantitative analysis of complex protein mixtures using isotope-coded affinity tags | Q28145324 | ||
| Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes | Q28238338 | ||
| Quantitative mass spectrometry in proteomics: a critical review | Q28238800 | ||
| Advances in high content screening for drug discovery | Q28256965 | ||
| The Connectivity Map: a new tool for biomedical research | Q28530408 | ||
| Topoisomerase levels determine chemotherapy responsein vitroandin vivo | Q29395563 | ||
| The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease | Q29547614 | ||
| Trastuzumab--mechanism of action and use in clinical practice | Q29615810 | ||
| Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis | Q30959874 | ||
| Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data | Q31147913 | ||
| An integrated platform of genomic assays reveals small-molecule bioactivities | Q33351287 | ||
| Target profiling of small molecules by chemical proteomics | Q33494810 | ||
| Proteomic and genetic approaches identify Syk as an AML target | Q33577098 | ||
| Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease | Q33628389 | ||
| Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment | Q33885419 | ||
| Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements. | Q33927283 | ||
| Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors | Q34005966 | ||
| Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug | Q34139151 | ||
| An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. | Q34582568 | ||
| Large-scale chemical dissection of mitochondrial function | Q34754716 | ||
| Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation | Q34956085 | ||
| Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress | Q35008361 | ||
| Transcript Profiling and RNA Interference as Tools To Identify Small Molecule Mechanisms and Therapeutic Potential | Q35063539 | ||
| Chemogenomic profiling: identifying the functional interactions of small molecules in yeast | Q35554300 | ||
| A method for high-throughput gene expression signature analysis | Q35606004 | ||
| Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer. | Q35670541 | ||
| Treatment of acute promyelocytic leukemia. | Q36662142 | ||
| Image-based chemical screening | Q36885394 | ||
| Identifying the proteins to which small-molecule probes and drugs bind in cells | Q37114227 | ||
| Acute promyelocytic leukemia: recent advances in diagnosis and management | Q37240576 | ||
| Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. | Q38290295 | ||
| Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators | Q40225712 | ||
| Genomic profiling of drug sensitivities via induced haploinsufficiency. | Q41614030 | ||
| Gefitinib induces myeloid differentiation of acute myeloid leukemia | Q42742416 | ||
| Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways | Q42871137 | ||
| Target identification using drug affinity responsive target stability (DARTS) | Q42959458 | ||
| A functional genomics approach to the mode of action of apratoxin A. | Q46146546 | ||
| Small-molecule reagents for cellular pull-down experiments | Q46809231 | ||
| Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation | Q75447880 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | proteomics | Q471857 |
| cancer | Q12078 | ||
| neoplasm | Q1216998 | ||
| antineoplastic | Q2853144 | ||
| P304 | page(s) | 254-261 | |
| P577 | publication date | 2011-12-13 | |
| 2012-01-17 | |||
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Genetic and proteomic approaches to identify cancer drug targets | |
| P478 | volume | 106 |
| Q39003101 | 7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells |
| Q50865512 | Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets |
| Q28834223 | Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines |
| Q54078591 | Isotope-coded, fluorous photoaffinity labeling reagents |
| Q39305667 | Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases |
| Q62496001 | Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery |
| Q40844582 | Profiling of the effects of antifungal agents on yeast cells based on morphometric analysis |
| Q92941579 | Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia |
| Q34564656 | Target identification of small molecules based on chemical biology approaches |
| Q91908379 | Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies |
| Q31115480 | Use of big data in drug development for precision medicine |
| Q37105464 | Venus Flytrap (Dionaea muscipula Solander ex Ellis) Contains Powerful Compounds that Prevent and Cure Cancer |
Search more.